title: New fluorinated 1,2,4-benzothiadiazine 1,1-dioxides: discovery of an orally active cognitive enhancer acting through potentiation of the 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid receptors.
abstract: In the search of a potent cognitive enhancer, a series of 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxides have been synthesized and evaluated as positive allosteric modulators of the AMPA receptors. In the present work, we focused our efforts on the insertion of mono- or polyfluoro-substituted alkyl chains at the 4-position of the thiadiazine ring in an attempt to enhance the pharmacokinetic behavior of previously described compounds. Among all the described compounds, 7-chloro-4-(2-fluoroethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide, 12b, was shown to exert a strong activity on AMPA receptors in vitro and a marked cognitive-enhancing effect in vivo after oral administration to Wistar rats. Considering its in vivo activity, the metabolic degradation of 12b was studied and compared to that of its nonfluorinated analogue 9b. Taken together, results of this study clearly validated the positive impact of the fluorine atom on the alkyl chain at the 4-position of benzothiadiazine dioxides on activity and metabolic stability.
authors.affiliation: Centre Interfacultaire de Recherche du Médicament, Laboratoire de Chimie Pharmaceutique, Université de Liège, Belgium. Pierre.Francotte@ulg.ac.be
authors.forename: Pierre
authors.initials: P
authors.lastname: Francotte
authors.forename: Eric
authors.initials: E
authors.lastname: Goffin
authors.forename: Pierre
authors.initials: P
authors.lastname: Fraikin
authors.forename: Pierre
authors.initials: P
authors.lastname: Lestage
authors.forename: Jean-Claude
authors.initials: JC
authors.lastname: Van Heugen
authors.forename: Florian
authors.initials: F
authors.lastname: Gillotin
authors.forename: Laurence
authors.initials: L
authors.lastname: Danober
authors.forename: Jean-Yves
authors.initials: JY
authors.lastname: Thomas
authors.forename: Patrice
authors.initials: P
authors.lastname: Chiap
authors.forename: Daniel-Henri
authors.initials: DH
authors.lastname: Caignard
authors.forename: Bernard
authors.initials: B
authors.lastname: Pirotte
authors.forename: Pascal
authors.initials: P
authors.lastname: de Tullio
mesh_terms: D000284:Administration, Oral; D000494:Allosteric Regulation; D000818:Animals; D001581:Benzothiadiazines / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D002478:Cells, Cultured; D003499:Cyclic S-Oxides / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D018683:Excitatory Amino Acid Agents / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D006624:Hippocampus / Q000187:drug effects / Q000502:physiology; D006801:Humans; D066298:In Vitro Techniques; D017774:Long-Term Potentiation / Q000187:drug effects; D008297:Male; D008862:Microsomes, Liver / Q000378:metabolism; D009474:Neurons / Q000187:drug effects / Q000502:physiology; D018697:Nootropic Agents / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D009865:Oocytes / Q000187:drug effects / Q000502:physiology; D018408:Patch-Clamp Techniques; D051381:Rats; D017208:Rats, Wistar; D018091:Receptors, AMPA / Q000502:physiology*; D021641:Recognition, Psychology / Q000187:drug effects; D013329:Structure-Activity Relationship; D014982:Xenopus laevis
chemical_list: C547951:7-chloro-4-(2-fluoroethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide; D001581:Benzothiadiazines; D003499:Cyclic S-Oxides; D018683:Excitatory Amino Acid Agents; D018697:Nootropic Agents; D018091:Receptors, AMPA